Bruker Corp (BRKR) Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release
Bruker Corp (BRKR) Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release
Bruker Corp (BRKR) Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release
Bruker Corp (BRKR) Sec Form 8K
Bruker Corp (NASDAQ: BRKR) Sec Form 8K
Bruker Corp (BRKR) Sec Form 8K
Bruker Corp (NASDAQ: BRKR) Sec Form 8K
Analysis
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook
Shares of Bruker Corporation (Nasdaq: BRKR) were down sharply in early trade on Friday, retreating around 10% to 14% after...
Bruker Corp (BRKR) Q4 2025 Earnings Call
Bruker Corp (NASDAQ: BRKR) Q4 2025 Earnings Conference
Bruker Corp (BRKR) Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration
Bruker Corp (NASDAQ: BRKR) FY 2026 Other Release
Bruker Corp (BRKR) Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Bruker Corp (NASDAQ: BRKR) FY 2026 Product Release
Bruker Corp (BRKR) Q2 2025 Earnings Call Transcript
Bruker Corp (NASDAQ: BRKR) Q2 2025 Earnings Call dated Aug. 04, 2025 Corporate Participants: Joe Kostka — Director, Investor Relations Frank H. Laukien — President…